News

Endpoints News12h
States sue US over plan for re­or­ga­ni­za­tion of fed­er­al health agen­cies
Attorneys general from 19 states and Washington, DC have filed a lawsuit against the federal government alleging that its ...
Endpoints News13h
Trump, Con­gress look at match­ing some US drug prices to costs abroad
House and Senate lawmakers from both parties are working with the Trump administration on proposals that would use drug ...
Endpoints News16h
Bri­an Arm­strong’s NewLim­it rais­es a $130M Se­ries B, lay­ing out road map for an­ti-ag­ing drugs
NewLimit raises $130M Series B led by Kleiner Perkins to advance epigenetic reprogramming research for liver disease ...
Endpoints News16h
Ver­tex paus­es study of mR­NA ther­a­py for cys­tic fi­bro­sis
Vertex paused an early-stage trial of its inhaled treatment for cystic fibrosis that came from a partnership with Moderna.
Endpoints News17h
Lil­ly to pay up to $415M in ALS deal; Ac­tu­ate’s mid-stage pan­cre­at­ic can­cer da­ta
Plus, news about Atara Bio­ther­a­peu­tics, Im­mutep, blue­bird bio, OSE Im­munother­a­peu­tics, Mer­sana Ther­a­peu­tics, ...
Endpoints News20h
Aldeyra plots third FDA fil­ing for dry eye dis­ease drug af­ter lat­est Phase 3 da­ta
Aldeyra Therapeutics reports Phase 3 success with reproxalap for dry eye disease, plans third FDA filing after previous ...